SCHEMBL572638

SCHEMBL572638

CCCCCCC(C(N)=O)C(C)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.48
SPHK1 Q9NYA1 2/20 0.48
FFAR1 O14842 2/20 0.48
EPHX1 P07099 1/20 0.47
CYP2D6 P10635 2/20 0.46
GMNN O75496 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
CETP P11597 1/20 0.46
HTT P42858 1/20 0.46
UBE2N P61088 1/20 0.46
GRIK1 P39086 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6577262 1.00 GPR84 (0.48) GPR84SPHK1FFAR1EPHX1CYP2D6
SCHEMBL5151362 1.00 GPR84 (0.48) GPR84SPHK1FFAR1EPHX1CYP2D6
SCHEMBL120519 1.00 GPR84 (0.48) GPR84SPHK1FFAR1EPHX1CYP2D6
SCHEMBL1299745 1.00 GPR84 (0.48) GPR84SPHK1FFAR1EPHX1CYP2D6
Propylene Glycol SCHEMBL4654734 0.93 CYP2D6 (0.49) GPR84SPHK1FFAR1EPHX1CYP2D6
SCHEMBL11340264 0.90 FAAH (0.54) FFAR1GMNNLMNAPOLBBLM
SCHEMBL10538672 0.90 FAAH (0.54) FFAR1GMNNLMNAPOLBBLM
SCHEMBL15329288 0.87 MAPT (0.54) GPR84FFAR1EPHX1MAPTGRIK1
SCHEMBL5145791 0.86 KDM4E (0.58) FFAR1LMNAKDM4ETP53CYP1A2
SCHEMBL7183545 0.86 EPHX1 (0.48) GPR84SPHK1FFAR1EPHX1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3503867-B1 TRANSPARENT COSMETIC CLEANSING COMPOSITION WITH IMPROVED RHEOLOGICAL PROFIL HENKEL AG & CO KGAA (DE) 2020-12-30 EP claimed
US-7754674-B2 Solvated non-ionic surfactants and fatty acids CRODA AMERICAS LLC (US) 2010-07-13 US claimed
US-20100080767-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2010-04-01 US claimed
EP-2082022-A1 COMPOUNDS Croda Uniqema Inc (US) 2009-07-29 EP claimed
EP-1643962-B1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS CRODA UNIQEMA INC (US) 2009-05-13 EP claimed
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids CRODA UNIQUEMA, INC. (US) 2009-04-23 US claimed
US-7479473-B2 Solvated nonionic surfactants and fatty acids CRODA UNIQEMA, INC. (US) 2009-01-20 US claimed
WO-2008063501-A1 COMPOUNDS CRODA UNIQEMA, INC. (US) 2008-05-29 WO claimed
EP-1643962-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI Americas, Inc. (US) 2006-04-12 EP claimed
US-6977082-B2 High efficacy antibacterial compositions having enhanced esthetic and skin care properties THE DIAL CORPORATION (US) 2005-12-20 US claimed
US-20050233929-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS, INC. (US) 2005-10-20 US claimed
US-20050026805-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS, INC. (US) 2005-02-03 US claimed
WO-2005007242-A1 SOLVATED NONIONIC SURFACTANTS AND FATTY ACIDS ICI AMERICAS, INC. (US) 2005-01-27 WO claimed
US-20050014671-A1 Solvated nonionic surfactants and fatty acids ICI AMERICAS INC. 2005-01-20 US claimed
EP-3600224-B1 SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2026-05-06 EP disclosed
EP-4683973-A2 DISPERSANT COMPOSITIONS COMPRISING HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, AND APPLICATIONS THEREOF ISP Investments LLC (US) 2026-01-28 EP disclosed
EP-3843694-B1 EMULSION-BASED PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME COLGATE PALMOLIVE CO (US) 2026-01-21 EP disclosed
US-20030069317-A1 High efficacy antibacterial compositions having enhanced esthetic and skin care properties HENKEL AG & CO. KGAA (DE) 2003-04-10 US disclosed
US-20030036498-A1 Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants ICI AMERICAS INC. 2003-02-20 US disclosed
WO-2002092740-A1 MIXED POLYALKYLENE GLYCOL HYDROXYALKYL ISOSTEARAMIDES AS RHEOLOGY ADJUVANTS ICI AMERICAS, INC. (US) 2002-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069317-A1 High efficacy antibacterial compositions having enhanced esthetic and skin care properties CUTA, RARA, SPOUT1 GPR84 1760/4885SPHK1 2828/4885FFAR1 941/4885
US-20100080767-A1 COMPOUNDS SREBF1, SGMS1, EBP GPR84 1245/4885SPHK1 594/4885FFAR1 255/4885
US-20050026805-A1 Solvated nonionic surfactants and fatty acids LIPC, PAOX, FASN GPR84 491/4885SPHK1 329/4885FFAR1 19/4885
US-20090105106-A1 Solvated non-ionic surfactants and fatty acids PAOX, FFAR3, ELOVL3 GPR84 611/4885SPHK1 323/4885FFAR1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.